☆ 4.7 Review

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes

Chirine Rafia et al.

Summary: The eradication of cancer remains a clinical challenge, and additional therapeutic strategies like immunotherapies need to be explored. It has been found that TGF-beta interferes with the antigenic activation of human V gamma 9V delta 2 T cells, impairing their cytolytic activity. These observations provide insights for understanding and targeting the impact of tumor microenvironment components on the antitumor activity of human T cell effectors.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Hematology

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition

Philippe Billiald et al.

Summary: This study shows that glenzocimab, a humanized antibody fragment, blocks the binding of GPVI to vascular collagen and fibrin through steric hindrance and structural change. This finding is significant for the development of new antiplatelet molecules with a low bleeding risk.

BLOOD ADVANCES (2023)

Add to Collection

Article Oncology

Inhibition of myeloperoxidase enhances immune checkpoint therapy for melanoma

Tracy W. Liu et al.

Summary: The presence of immune suppressing myeloid cells in the tumor microenvironment limits the success of immune checkpoint therapy (ICT). In this study, the researchers found that removing or inhibiting myeloperoxidase (MPO) can enhance the response to ICT in aged mice with primary melanoma. The tumor microenvironment and systemic immune landscape experienced significant changes, and repurposing MPO-specific inhibitors showed promising results in combination with ICT.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Add to Collection

Article Oncology

Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy

Magdalena Zaborowska-Szmit et al.

Summary: Concurrent platinum-based chemoradiotherapy (CRT) followed by maintenance treatment with the PD-L1 inhibitor durvalumab is the most effective therapy in unresectable stage III non-small-cell lung cancer (NSCLC). However, severe toxicity may lead to unsatisfactory outcomes. Sequential CRT may be a better choice for patients with cardiovascular diseases (CVD) to avoid adverse events and maintain effectiveness. Beta-blockers and statins can significantly reduce all-cause mortality in these patients, and may serve as a prevention strategy in NSCLC patients undergoing CRT.

CANCERS (2023)

Add to Collection

Review Oncology

TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach

Valeria Ramundo et al.

Summary: Lung cancer (LC) is the leading cause of cancer incidence and mortality worldwide. LC is associated with genetic mutations, environmental factors (smoking), or pathological conditions, and has a poor prognosis and limited pharmacological options. TGF-beta is a molecule that regulates biological processes in the lungs and its alteration is linked to LC development and metastasis. Studies have shown that TGF-beta overexpression could serve as a predictive marker for LC prognosis, and inhibition of TGF-beta can prevent metastasis and improve patient survival. Targeting TGF-beta may be a valid strategy to fight against LC and provide novel and effective treatment options for this aggressive cancer.

CANCERS (2023)

Add to Collection

Article Oncology

Platelet Count and Survival after Cancer

Vasily Giannakeas et al.

Summary: Research shows that platelet count in cancer patients is associated with survival rates, with higher counts correlating with poorer survival and lower counts with better survival. Platelet count could potentially serve as a risk assessment measure for cancer patients.

CANCERS (2022)

Add to Collection

Review Oncology

Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types

Ana-Luisa Palacios-Acedo et al.

Summary: This study compares the interactions between cancer cells and platelets in three different cancer types with varying thrombotic risks: oral cancer (low risk), colorectal cancer (medium risk), and pancreatic cancer (high risk). Understanding these interactions is crucial for finding new biomarkers and therapeutic targets for cancer-associated thrombosis.

CANCERS (2022)

Add to Collection

Article Medicine, General & Internal

Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period

Vasily Giannakeas et al.

Summary: Elevated platelet count is associated with increased risk of cancer at multiple sites, but the odds ratios decrease with time from CBC test to cancer diagnosis. The findings suggest that elevated platelet count could potentially serve as a marker for certain types of cancer.

JAMA NETWORK OPEN (2022)

Add to Collection

Review Immunology

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives

Jiaqi Liang et al.

Summary: Regulatory T cells play a significant role in non-small-cell lung cancer (NSCLC), promoting tumor growth and metastasis by influencing the tumor microenvironment. Therefore, targeting these T cells has become a novel direction for NSCLC treatment.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Oncology

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors

Fabrice Barlesi et al.

Summary: Bintrafusp alfa showed some clinical activity and a manageable safety profile in heavily pretreated NSCLC patients.

ONCOLOGIST (2022)

Add to Collection

Review Immunology

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy

Ming Yi et al.

Summary: TGF-beta signaling has predictive value in cancer immunotherapy, and targeted therapies against TGF-beta are important strategies to overcome treatment resistance.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

SMAD4, activated by the TCR-triggered MEK/ERK signaling pathway, critically regulates CD8+T cell cytotoxic function

Xinwei Liu et al.

Summary: In this study, the researchers found that SMAD4 plays a critical role in promoting CD8(+) T cell function in both tumor and infection models. SMAD4-mediated transcriptional regulation enhances CD8(+) T cell activation and cytotoxicity through the T cell receptor (TCR) signaling pathway. Furthermore, SMAD4 is directly phosphorylated by ERK following TCR activation.

SCIENCE ADVANCES (2022)

Add to Collection

Review Oncology

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy

Wiktoria Strasenburg et al.

Summary: Tumor cells can induce platelet activation and aggregation, facilitating tumor progression. Platelets protect tumor cells, provide growth factors, and promote metastasis. Specific factors developed by cancer cells, such as coagulation factors, adhesion receptors, and growth factors, can trigger platelet aggregation. Targeting tumor cell-induced platelet aggregation (TCIPA) may lead to new treatment modalities.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Cardiovascular disease and risk of lung cancer incidence and mortality: A nationwide matched cohort study

Ce Wang et al.

Summary: The study found that patients with cardiovascular disease (CVD) are more likely to develop lung cancer and have a higher risk of lung cancer mortality, especially those with heart disease and vascular disease. Individuals diagnosed with CVD in middle adulthood have a higher risk of developing lung cancer.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Immunology

Correlations between Circulating and Tumor-Infiltrating CD4+ Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages

Mohammad A. Al-Mterin et al.

Summary: This study investigates the correlations between T regulatory cell subsets and immune checkpoint-expressing CD4(+) T cells in colorectal cancer patients. The findings show that these highly immunosuppressive cells have the potential to inhibit inflammatory responses in the tumor microenvironment. Understanding these correlations can enhance our understanding of the mechanisms of Treg-mediated immunosuppression in cancer.

VACCINES (2022)

Add to Collection

Article Oncology

Risk Factors and Impact on Outcomes of Lung Cancer Patients Concurrent with Deep Vein Thrombosis

Yi-fan Jin et al.

Summary: This study found that deep vein thrombosis (DVT) is a potential complication in patients with lung adenocarcinoma and could result in an unfavorable prognosis. Screening for DVT in high-risk adenocarcinoma patients is essential.

CANCER CONTROL (2022)

Add to Collection

Review Pharmacology & Pharmacy

Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression

Kristen Fousek et al.

Summary: IL-8 plays a significant role in the tumor microenvironment by affecting tumor cell proliferation, invasiveness, drug resistance, and immune cell killing capacity, thereby impacting the efficacy of immunotherapy.

PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Review Medicine, Research & Experimental

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression

Jitske van den Bulk et al.

Summary: TGF-beta plays a crucial role in regulating immune cell activity and promoting malignant features in cancer. Targeting TGF-beta therapeutically may enhance the success of immunotherapies.

CLINICAL SCIENCE (2021)

Add to Collection

Article Hematology

Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer

Yohei Hisada et al.

Summary: This study investigated the association of active Lys-PG in plasma and VTE in pancreatic cancer patients, as well as the impact of human pancreatic tumors expressing Lys-PG on venous thrombus resolution in mice. The results suggest that Lys-PG may contribute to the development of VTE in pancreatic cancer.

BLOOD ADVANCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer

Clemens Hinterleitner et al.

Summary: This study demonstrates that platelet-derived PD-L1 can serve as a prognostic and predictive biomarker in non-small cell lung cancer patients, playing a role in tumor immune evasion and affecting T cell function. An algorithm was developed to calculate the adjusted PD-L1 payload of platelets (pPD-L1(Adj.)), which showed superior predictive ability for therapy response compared to standard histological PD-L1 quantification.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Hematology

Platelets and extracellular vesicles and their cross talk with cancer

Sophia Lazar et al.

Summary: This review provides an overview of the complex roles of platelet-derived microvesicles (PMVs) in cancer development and progression, including promoting disease progression and anti-tumor functions, as well as their effects on cancer cells and non-transformed cells in the tumor microenvironment. Additionally, PMVs play a role in coagulation, thrombosis, and interactions with inflammatory cells, but separating the effects of PMVs from platelets in cancer contexts remains a challenge.

BLOOD (2021)

Add to Collection

Review Hematology

Lessons to learn from tumor-educated platelets

Harvey G. Roweth et al.

Summary: Platelets, beyond their traditional roles in hemostasis and thrombosis, are now recognized as mediators of malignant disease, particularly in cancer progression and metastasis. Platelets isolated from cancer patients, known as tumor-educated platelets, show distinct RNA and protein profiles, making them a potential liquid biopsy for early cancer detection. Mechanisms include direct uptake of tumor-derived factors, signal-dependent RNA processing changes, and differential platelet production by tumor-educated megakaryocytes.

BLOOD (2021)

Add to Collection

Review Hematology

Aspirin and antiplatelet treatments in cancer

Derrick L. Tao et al.

Summary: Experimental research indicates that reducing platelet count or activity could slow down cancer progression and enhance treatment results. Various factors like injury, inflammation, cancer, and infection can affect blood cell counts.

BLOOD (2021)

Add to Collection

Review Immunology

Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

Byeong-Oh Hwang et al.

Summary: Cancer tissues form complex and heterogeneous tumor microenvironments, where platelets play a crucial role in promoting cancer progression. In oral squamous cell carcinoma, high platelet counts and low tumor-stromal ratio are associated with increased metastasis and poor prognosis, suggesting that targeting the interaction between platelets and cancer cells could be a promising therapeutic strategy to inhibit cancer invasion and metastasis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Blood Platelets as an Important but Underrated Circulating Source of TGFβ

Kamil Karolczak et al.

Summary: Platelets are key regulators of TGF beta levels, but there is limited research on developing platelet-directed therapies; however, promising reports suggest that platelet TGF beta may play specific roles in cardiovascular diseases, liver fibrosis, tumor metastasis, cerebral malaria, and inflammatory cell function regulation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Medical Laboratory Technology

Identification of seven tumor-educated platelets RNAs for cancer diagnosis

Xinxin Ge et al.

Summary: This study identified 7 TEPs liquid-biopsy biomarkers that may be used for cancer diagnosis and monitoring. These biomarkers include RSL24D1, IFI27, CRYM, HBD, IFITM3, FCGR2A, and KLHDC8B. These genes showed potential for diagnosing early and advanced stage cancers.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Add to Collection

Review Oncology

The association between thrombocytosis and subtype of lung cancer: a systematic review and meta-analysis

Melissa Barlow et al.

Summary: Thrombocytosis is not significantly predictive of a specific subtype of lung cancer, with similar prevalence and mean platelet count across different histological and genetic subtypes. High platelet count is likely a common characteristic among all subtypes of lung cancer.

TRANSLATIONAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Tingting Liu et al.

Summary: The study found that NMPs and PMPs are associated with disease progression in advanced NSCLC. The predictive model established combining NMPs, PMPs, and NLR can screen out 80.8% of patients with progressive disease.

BMC CANCER (2021)

Add to Collection

Review Oncology

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

Daniel R. Principe et al.

Summary: ICIs have revolutionized lung cancer treatment, but further research on immunosuppressive mechanisms in the lung cancer microenvironment is crucial for improving efficacy.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Oncology

Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues

Attila Braun et al.

Summary: Platelets play a critical role in thrombosis and hemostasis, but they also promote tumor progression and metastasis through various interactions with cancer cells. Anti-platelet agents might hold potential for cancer prevention and treatment by targeting these interactions between platelets, tumor cells, and the host microenvironment.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Serum IL-6 as a vital predictor of severe lung cancer

Jian An et al.

Summary: The study revealed that elevated IL-6 levels are associated with worse performance status and predict progressive disease in severe lung cancer patients, highlighting the importance of monitoring IL-6 levels as a strategy to improve prognosis in these patients.

ANNALS OF PALLIATIVE MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Platelet Microparticle Controversial Role in Cancer

Mahnaz Nazari et al.

Summary: Platelet-derived microparticles (PMPs) are micrometer-scale extracellular vesicles released by platelets upon activation, and their potential roles and effects in cancer progression have been conflictingly implicated. Understanding the intricate interplay between PMPs and cancer is crucial for future considerations of PMPs usage in cancer targeted therapy.

ADVANCED PHARMACEUTICAL BULLETIN (2021)

Add to Collection

Article Oncology

The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis

Lea Plantureux et al.

CANCER RESEARCH (2020)

Add to Collection

Review Hematology

A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection

Martin J. Page et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Add to Collection

Review Respiratory System

Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis

Yuan Yuan et al.

BMC PULMONARY MEDICINE (2020)

Add to Collection

Article Hematology

Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets

Tessa J. Barrett et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Primary Health Care

Cancer incidence following a high-nor a platelet count: cohort study using electronic healthcare records from English primary care

Luke T. A. Mounce et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2020)

Add to Collection

Article Medicine, General & Internal

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

John Burn et al.

LANCET (2020)

Add to Collection

Article Oncology

Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer

Atul Batra et al.

BMC CANCER (2020)

Add to Collection

Article Multidisciplinary Sciences

TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer

Bit Na Kim et al.

Scientific Reports (2020)

Add to Collection

Article Multidisciplinary Sciences

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Gregoire de Streel et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Engineering, Biomedical

In vitro Studies of Transendothelial Migration for Biological and Drug Discovery

Alec T. Salminen et al.

FRONTIERS IN MEDICAL TECHNOLOGY (2020)

Add to Collection

Article Oncology

Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer

Qing Xia et al.

JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis

Ying Zhu et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Add to Collection

Editorial Material Oncology

The History of Armand Trousseau and Cancer-Associated Thrombosis

Pat Metharom et al.

CANCERS (2019)

Add to Collection

Review Immunology

Transforming Growth Factor-β Signaling in Immunity and Cancer

Eduard Batlle et al.

IMMUNITY (2019)

Add to Collection

Article Immunology

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

Deepali Sawant et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Oncology

Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma

Mengqiao Xu et al.

BMC CANCER (2019)

Add to Collection

Review Oncology

Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis

Jue Li et al.

BMC CANCER (2019)

Add to Collection

Article Medicine, Research & Experimental

Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ T cells

Magdalena J. Polanczyk et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Add to Collection

Review Hematology

Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin

Katsue Suzuki-Inoue

BLOOD (2019)

Add to Collection

Review Oncology

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding

Marta Helena Kubala et al.

CANCER AND METASTASIS REVIEWS (2019)

Add to Collection

Review Physiology

Platelet Biogenesis in the Lung Circulation

Emma Lefrancais et al.

PHYSIOLOGY (2019)

Add to Collection

Review Immunology

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Mariya Lazarova et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Oncology

Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies

Corinne Frere et al.

CANCERS (2019)

Add to Collection

Article Immunology

Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells

Billur Akkaya et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis

Yuta Yamanaka et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2019)

Add to Collection

Article Hematology

Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells

Barbara Costa et al.

BLOOD ADVANCES (2019)

Add to Collection

Review Respiratory System

Cancer-associated thrombosis: the when, how and why

Caio J. Fernandes et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Add to Collection

Article Multidisciplinary Sciences

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion

Jeong Uk Lim et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside

Jae Youn Moon et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2018)

Add to Collection

Article Oncology

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

Nicole M. Kuderer et al.

ONCOLOGIST (2018)

Add to Collection

Review Oncology

Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring

Myron G. Best et al.

CANCER RESEARCH (2018)

Add to Collection

Review Cell Biology

Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches

Jelle J. F. Sleeboom et al.

DISEASE MODELS & MECHANISMS (2018)

Add to Collection

Review Oncology

Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer

Alessandra Metelli et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration

James M. Fox et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger

Catherine E. Handy et al.

CIRCULATION (2018)

Add to Collection

Review Medicine, Research & Experimental

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

Ali Masjedi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Review Oncology

Role of platelets and platelet receptors in cancer metastasis

Martin Schlesinger

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages

Meili Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Add to Collection

Review Immunology

Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune Diseases

Xu Wang et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Oncology

Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis

Lea Plantureux et al.

CANCERS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

TGF-beta downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade

Zhezhu Han et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Add to Collection

Correction Oncology

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data (vol 115, pg 115, 2016)

Alex J. Walker et al.

BRITISH JOURNAL OF CANCER (2017)

Add to Collection

Article Medicine, Research & Experimental

Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis

Ying Wei et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Add to Collection

Article Hematology

C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice

T. Shirai et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

Add to Collection

Article Multidisciplinary Sciences

The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors

Emma Lefrancais et al.

NATURE (2017)

Add to Collection

Article Genetics & Heredity

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

James D. McKay et al.

NATURE GENETICS (2017)

Add to Collection

Article Multidisciplinary Sciences

Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation

Kenichi Miyata et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Biotechnology & Applied Microbiology

Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer

Xianming Fei et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Add to Collection

Article Oncology

Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer

Sookyung Lee et al.

JOURNAL OF CANCER (2017)

Add to Collection

Review Immunology

The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders

Annette J. Theron et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models

Agnieszka Denslow et al.

PLOS ONE (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cancer and Thrombotic Risk: The Platelet Paradigm

Elizabeth C. Lee et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2017)

Add to Collection

Review Cell Biology

Cancer and Thrombosis: The Platelet Perspective

Claire K. S. Meikle et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Human lung tumor FOXP+ Tregs upregulate four Treg-locking transcription factors

Tatiana Akimova et al.

JCI INSIGHT (2017)

Add to Collection

Article Immunology

Platelets subvert T cell immunity against cancer via GARP-TGFβ axis

Saleh Rachidi et al.

SCIENCE IMMUNOLOGY (2017)

Add to Collection

Article Hematology

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl et al.

BLOOD (2017)

Add to Collection

Article Pharmacology & Pharmacy

Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma

Troels K. Bergmann et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sebastien Viel et al.

SCIENCE SIGNALING (2016)

Add to Collection

Review Hematology

Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences

Soraya Mezouar et al.

THROMBOSIS RESEARCH (2016)

Add to Collection

Article Hematology

Epidemiology of venous thromboembolism in the Framingham Heart Study

Marja K. Puurunen et al.

THROMBOSIS RESEARCH (2016)

Add to Collection

Article Oncology

TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype

Fan Zhang et al.

ONCOTARGET (2016)

Add to Collection

Article Cell Biology

PF4 Promotes Platelet Production and Lung Cancer Growth

Ferdinando Pucci et al.

CELL REPORTS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sebastien Viel et al.

SCIENCE SIGNALING (2016)

Add to Collection

Article Oncology

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

Myron G. Best et al.

CANCER CELL (2015)

Add to Collection

Article Oncology

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis

Julia Kravchenko et al.

LUNG CANCER (2015)

Add to Collection

Review Respiratory System

Venous thromboembolism and lung cancer: a review

Carolina Vitale et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE (2015)

Add to Collection

Article Oncology

Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients

Eric A. Engels et al.

CANCER MEDICINE (2015)

Add to Collection

Article Cell Biology

Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients

Yongling Ji et al.

PLATELETS (2015)

Add to Collection

Article Oncology

Experimental Study on Inhibition Effects of the XAF1 Gene against Lung Cancer Cell Proliferation

Wen-Tao Yang et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Article Critical Care Medicine

Prevalence and Associations of VTE in Patients With Newly Diagnosed Lung Cancer

Yuhui Zhang et al.

CHEST (2014)

Add to Collection

Article Immunology

Human CD4+CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells

P. J. Schuler et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)

Add to Collection

Review Hematology

Platelets in cancer and thrombosis

J. Riedl et al.

HAMOSTASEOLOGIE (2014)

Add to Collection

Article Dermatology

Increased Levels of Circulating Microparticles Are Associated with Increased Procoagulant Activity in Patients with Cutaneous Malignant Melanoma

Claire Laresche et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Add to Collection

Review Cell Biology

The Inflammatory Chemokine CCL5 and Cancer Progression

Donatella Aldinucci et al.

MEDIATORS OF INFLAMMATION (2014)

Add to Collection

Review Immunology

The two faces of IL-6 in the tumor microenvironment

Daniel T. Fisher et al.

SEMINARS IN IMMUNOLOGY (2014)

Add to Collection

Review Oncology

Involvement of Platelet-Derived Microparticles in Tumor Progression and Thrombosis

Soraya Mezouar et al.

SEMINARS IN ONCOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

Bohdan Kadlec et al.

SCIENTIFIC WORLD JOURNAL (2014)

Add to Collection

Article Hematology

Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients

Y. Nadir et al.

THROMBOSIS RESEARCH (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value

Chia-Cheng Tseng et al.

DISEASE MARKERS (2013)

Add to Collection

Article Medicine, Research & Experimental

Platelet count predicts prognosis in operable non-small cell lung cancer

Dangfan Yu et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)

Add to Collection

Article Oncology

Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer

G. C. Connolly et al.

LUNG CANCER (2012)

Add to Collection

Article Oncology

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

Myriam Labelle et al.

CANCER CELL (2011)

Add to Collection

Article Medicine, General & Internal

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

John Burn et al.

LANCET (2011)

Add to Collection

Review Biotechnology & Applied Microbiology

Initial steps of metastasis: Cell invasion and endothelial transmigration

Franziska van Zijl et al.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)

Add to Collection

Article Multidisciplinary Sciences

New gene functions in megakaryopoiesis and platelet formation

Christian Gieger et al.

NATURE (2011)

Add to Collection

Article Immunology

Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development

Weiming Ouyang et al.

IMMUNITY (2010)

Add to Collection

Article Oncology

Platelet count: association with prognosis in lung cancer

Francisco Javier Gonzalez Barcala et al.

MEDICAL ONCOLOGY (2010)

Add to Collection

Article Hematology

Microparticles in Cancer

Janusz Rak

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)

Add to Collection

Article Hematology

The incidence of venous thromboembolism among patients with primary lung cancer

H. K. Chew et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)

Add to Collection

Letter Hematology

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)

Add to Collection

Review Multidisciplinary Sciences

Platelet aggregation in the formation of tumor metastasis

Takashi Tsuruo et al.

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2008)

Add to Collection

Article Hematology

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells:: hydrolysis of extracellular ATP and immune suppression

Giovanna Borsellino et al.

BLOOD (2007)

Add to Collection

Article Oncology

High risk of deep vein thrombosis in patients with non-small cell lung cancer: A cohort study of 493 patients

Vicky Tagalakis et al.

JOURNAL OF THORACIC ONCOLOGY (2007)

Add to Collection

Article Hematology

Microvesicle-associated tissue factor and Trousseau's syndrome

I. Del Conde et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Add to Collection

Letter Hematology

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Add to Collection

Article Respiratory System

Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma

T. Sato et al.

THORAX (2006)

Add to Collection

Article Public, Environmental & Occupational Health

Platelet counts differ by sex, ethnicity, and age in the United States

JB Segal et al.

ANNALS OF EPIDEMIOLOGY (2006)

Add to Collection

Article Oncology

TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

DA Thomas et al.

CANCER CELL (2005)

Add to Collection

Article Cardiac & Cardiovascular Systems

Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization

A Brill et al.

CARDIOVASCULAR RESEARCH (2005)

Add to Collection

Article Oncology

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

A Janowska-Wieczorek et al.

INTERNATIONAL JOURNAL OF CANCER (2005)

Add to Collection

Article Hematology

Platelet microparticles induce angiogenesis in vitro

HK Kim et al.

BRITISH JOURNAL OF HAEMATOLOGY (2004)

Add to Collection

Article Immunology

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3

WJ Chen et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)

Add to Collection

Review Oncology

Platelets and cancer

GF Nash et al.

LANCET ONCOLOGY (2002)

Add to Collection

Article Immunology

Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation

L Gorelik et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2002)

Add to Collection

Article Hematology

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

A Kaser et al.

BLOOD (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.